BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32909893)

  • 41. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial.
    Adam DJ; Beard JD; Cleveland T; Bell J; Bradbury AW; Forbes JF; Fowkes FG; Gillepsie I; Ruckley CV; Raab G; Storkey H;
    Lancet; 2005 Dec; 366(9501):1925-34. PubMed ID: 16325694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aorto-iliac and infrainguinal artery occlusive disease: different revascularization options according to the critical limb threatening ischemia category.
    Pini R; Faggioli G; Angherà C; Cappiello A; Abualhin M; Pomatto S; Gallitto E; Gargiulo M
    Int Angiol; 2023 Jun; 42(3):209-215. PubMed ID: 37067388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Paclitaxel-coated peripheral arterial devices are associated with improved overall survival and limb salvage in patients with chronic limb-threatening ischemia.
    Kumins NH; King AH; Ambani RN; Cho JS; Harth KC; Wong VL; Colvard B; Bose S; Thomas JP; Kashyap VS
    J Vasc Surg; 2021 Nov; 74(5):1682-1688.e1. PubMed ID: 34090989
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Outcomes and Patency of Endovascular Infrapopliteal Reinterventions in Patients With Chronic Limb-Threatening Ischemia.
    Kleiss SF; van Mierlo-van den Broek PAH; Vos CG; Fioole B; Bloemsma GC; de Vries-Werson DAB; Bokkers RPH; de Vries JPM
    J Endovasc Ther; 2023 Jan; ():15266028221147457. PubMed ID: 36609175
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk Factor Analysis and Long-Term Outcomes in Patients with Endovascular Revascularization for Intermittent Claudication or Chronic Limb-Threatening Ischemia.
    Fung V; Chan YC; Cheung GC; Cheng SW
    Ann Vasc Surg; 2023 Feb; 89():261-268. PubMed ID: 36162626
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Results for primary bypass versus primary angioplasty/stent for lower extremity chronic limb-threatening ischemia.
    Darling JD; McCallum JC; Soden PA; Korepta L; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2017 Aug; 66(2):466-475. PubMed ID: 28274753
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Editor's Choice - Infra-inguinal Endovascular Revascularisation and Bypass Surgery for Chronic Limb Threatening Ischaemia: a Retrospective European Multicentre Cohort Study with Propensity Score Matching.
    Ricco JB; Roiger RJ; Schneider F; Guetarni F; Thaveau F; Illuminati G; Pasqua R; Chaufour X; Porterie J; Hostalrich A
    Eur J Vasc Endovasc Surg; 2023 Oct; 66(4):531-540. PubMed ID: 37385368
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of global limb anatomic staging system for patients with chronic limb-threatening ischemia treated with autogenous bypass grafts.
    Soares TR; Cabral G; Costa T; Tiago J; Gimenez J; Duarte A; Cunha E Sá D
    J Vasc Surg; 2022 Nov; 76(5):1347-1353.e2. PubMed ID: 35738475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program.
    Causey MW; Ahmed A; Wu B; Gasper WJ; Reyzelman A; Vartanian SM; Hiramoto JS; Conte MS
    J Vasc Surg; 2016 Jun; 63(6):1563-1573.e2. PubMed ID: 27036309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-Coated Balloon Angioplasty of Infrapopliteal Lesions in Chronic Limb-Threatening Ischemia: Six-month Outcomes of PRIME-WIFI.
    Guo J; Ye M; Zhang W; Wu Z; Feng Z; Fang X; Li Q; Sang H; Shi Z; Shi W; He C; Gao X; Guo J; Tong Z; Gu Y; Guo L
    J Endovasc Ther; 2023 Nov; ():15266028231208646. PubMed ID: 37919946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes after first-time lower extremity revascularization for chronic limb-threatening ischemia in insulin-dependent diabetic patients.
    Darling JD; O'Donnell TFX; Deery SE; Norman AV; Vu GH; Guzman RJ; Wyers MC; Hamdan AD; Schermerhorn ML
    J Vasc Surg; 2018 Nov; 68(5):1455-1464.e1. PubMed ID: 30360841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extent of heel ulceration influences the outcomes in patients with isolated infrapopliteal limb threatening critical ischemia.
    Yan Q; Jayakumar L; Sideman MJ; Ferrer L; Mitromaras C; Miserlis D; Davies MG
    J Vasc Surg; 2021 May; 73(5):1731-1740.e2. PubMed ID: 33031885
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bypass surgery versus endovascular revascularization for occlusive infrainguinal peripheral artery disease: a meta-analysis of randomized controlled trials for the development of the Italian Guidelines for the treatment of diabetic foot syndrome.
    Scatena A; Apicella M; Mantuano M; Liistro F; Ventoruzzo G; Petruzzi P; Miranda C; Monge L; Ragghianti B; Silverii A; Ferraro I; Uccioli L; Vermigli C; Mannucci E; Scevola G; Stabile E; Gargiulo M; Monami M; ;
    Acta Diabetol; 2024 Jan; 61(1):19-28. PubMed ID: 37792028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Utility of a novel high pressure non-compliant balloon for tibial atherosclerotic lesions in Asian patients with chronic limb threatening ischaemia.
    Tang TY; Lee SQW; Chan SL; Yap CJQ; Soon SXY; Chong TT; Choke ETC; Yan BPY
    Vasa; 2020 Oct; 49(6):475-482. PubMed ID: 32693707
    [No Abstract]   [Full Text] [Related]  

  • 56. P2Y12 inhibitor monotherapy is associated with superior outcomes as compared with aspirin monotherapy in chronic limb-threatening ischemia.
    Khan SZ; O'Brien-Irr MS; Fakhoury E; Montross B; Rivero M; Dosluoglu HH; Harris LM; Dryjski ML
    J Vasc Surg; 2022 Oct; 76(4):1053-1059. PubMed ID: 35709863
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of Statins on Survival and Limb Salvage in Patients Undergoing Peripheral Endovascular Intervention for Chronic Limb-Threatening Ischemia.
    Chang M; O'Brien-Irr M; Montross B; Dosluoglu H; Harris L; Dryjski M; Rivero M; Khan SZ
    Ann Vasc Surg; 2023 Apr; 91():20-27. PubMed ID: 36503021
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: what are its implications?
    Bradbury AW
    Semin Vasc Surg; 2009 Dec; 22(4):267-74. PubMed ID: 20006808
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endovascular Therapy Provides Similar Results of Bypass Graft Surgery in the Treatment of Infrainguinal Multilevel Arterial Disease in Patients with Chronic Limb-Threatening Ischemia in All GLASS Stages.
    Casella IB; Sartori CH; Faustino CB; Vieira Mariz MP; Presti C; Puech-Leão P; De Luccia N
    Ann Vasc Surg; 2020 Oct; 68():400-408. PubMed ID: 32339688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) and the (hoped for) dawn of evidence-based treatment for advanced limb ischemia.
    Conte MS
    J Vasc Surg; 2010 May; 51(5 Suppl):69S-75S. PubMed ID: 20435263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.